Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals.

AIDS (London, England) - 24 Aug 2009

Matthews Gail V, Seaberg Eric, Dore Gregory J, Bowden Scott, Lewin Sharon R, Sasadeusz Joe, Marks Pip, Goodman Zachary, Philp Frances H, Tang Yiwei, Locarnini Stephen, Thio Chloe L

Abstract excerpt

OBJECTIVES: To determine if highly active antiretroviral therapy (HAART) with combination anti-hepatitis B virus (HBV) therapy compared to HAART with HBV monotherapy leads to greater HBV DNA suppression in an HIV/HBV coinfected cohort. DESIGN: A cross-sectional analysis of 122 HIV/HBV coinfected patients from Australia and the United States. METHODS: Univariate analysis and ordinal logistic regression were used...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4 Lymphocyte Count

Share to Hepatitis B

Share to Hepatitis B virus

Share to Lamivudine

Share to Liver Cirrhosis

Share to Viral Load

Source

Open in PubMed Open full text

Identifiers

PMID: 19584701
DOI: 10.1097/QAD.0b013e32832b43f2
PMCID: PMC2918388

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combination HBV therapy is linked to greater HBV DNA suppression in a cohort of lamivudine-experienced HIV/HBV coinfected individuals.PMID 19584701Read ↗

Comparison of HBV-active HAART regimens in an HIV-HBV multinational cohort: outcomes through 144 weeks.Semantic proximity Read ↗

Treatment of hepatitis B with lamivudine and tenofovir in HIV/HBV-coinfected patients: factors associated with response.Semantic proximity Read ↗

Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B.Semantic proximity Read ↗

Virology and clinical sequelae of long-term antiviral therapy in a North American cohort of hepatitis B virus (HBV)/human immunodeficiency virus type 1 (HIV-1) co-infected patients.Semantic proximity Read ↗

Hepatitis B virus genetic multiplicity and the associated HBV lamivudine resistance mutations in HBV/HIV co-infection in Western Kenya: A review article.Semantic proximity Read ↗

Short-term treatment outcomes in human immunodeficiency virus type-1 and hepatitis B virus co-infections.Semantic proximity Read ↗

High frequency of lamivudine resistance mutations in Brazilian patients co-infected with HIV and hepatitis B.Semantic proximity Read ↗

Long-term hepatitis B virus (HBV) response to lamivudine-containing highly active antiretroviral therapy in HIV-HBV co-infected patients in Thailand.Semantic proximity Read ↗

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons.Semantic proximity Read ↗

Mutations associated with lamivudine-resistance in therapy-naïve hepatitis B virus (HBV) infected patients with and without HIV co-infection: implications for antiretroviral therapy in HBV and HIV co-infected South African patients.Semantic proximity Read ↗

Differential clinical and virologic impact of hepatitis B virus genotypes B and C on HIV-coinfected patients receiving lamivudine-containing highly active antiretroviral therapy.Semantic proximity Read ↗

HBV infection in untreated HIV-infected adults in Maputo, Mozambique.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.